LEPTIN AND ADIPONECTIN CONTENT IN BLOOD SERUM AND RECEPTOR EXPRESSION IN OSTEOPENIA AND OSTEOPOROSIS IN PATIENTS SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Abstract
The purpose is to identify the leptin and adiponectin content in blood regarding their receptor expression in the soft tissue of the hip in case of chronic obstructive pulmonary disease with the signs of osteporosis.
80 COPD patients and 76 healthy persons were examined. Receptor expression to leptin and adiponectin in the vessels was tested by immune-fluorescent technique in 30 patients.
Control leptin and adiponectin expression was presented in skin, subcutaneous fat and cross-striped muscles. In case of COPD leptin and adiponectin expression was identified in skin and subcutaneous fat. In control cases and COPD leptin expression was identified in endothelium and myocytes achieving confident reduction at stages II and III. Adiponectin expression in control cases and in stage I was detection only in adventitia. In stages II and III stages adiponectin is expressed in myocytes and endothelium. Receptor expression to leptin and adiponectin repeats their content in blood. The correlations between leptin and adiponectin and their expression with body mass index and mineral bone density have been found out.
The detected changes confirm the contribution of adiponectin to re-modeling of muscle and bone tissue in case of COPD.
About the Authors
L. G. Ugay
Pacific State Medical University
Russian Federation
Vladivostok
Russian Federation
Vladivostok
V. A. Nevzorova
Pacific State Medical University
Russian Federation
Vladivostok
Russian Federation
Vladivostok
E. A. Kochetkova
Pacific State Medical University
Russian Federation
Vladivostok
Russian Federation
Vladivostok
E. V. Burtseva
Pacific State Medical University
Russian Federation
Vladivostok
Russian Federation
Vladivostok
Yu. V. Maystrovskaya
Pacific State Medical University
Russian Federation
Vladivostok
Russian Federation
Vladivostok
References
1. Kochetkova E.A., Ugay L.G., Maystrovskaya Yu.V. et al. New mechanisms of osteoporosis formation in terminal pulmonary pathology. Tikhooneansky Meditsinsky Journal, 2013, no. 4, pp. 72-75. (In Russ.)
2. Brúsik M., Ukropec J., Joppa P. et al. Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease. Physiol Res., 2012, vol. 61, no. 5, pp. 469-80.
3. Calikoglu M., Sahin G., Unlu A. et al. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration, 2004, vol. 71, no. 1, pp. 45-50.
4. Chen S.J., Liao W.C., Huang K.H. et al. Chronic obstructive pulmonary disease is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM 2015 Jan 21. [Epub ahead of print].
5. Julia C., Czernichow S., Charnaux N. et al. Relationships between adipokines, biomarkers of endothelial function and inflammation and risk of type 2 diabetes. Diabetes Res. Clin. Pract., 2014, vol. 105, no. 2, pp. 231-238.
6. Liu Y., Song C.Y., Wu S.S. et al. Novel adipokines and bone metabolism. Int. J. Endocrinol., 2013; 2013:895045.doi: 10.1155/2013/895045.
7. Nakanishi K., Takeda Y., Tetsumoto S. et al. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. Am. J. Respir. Crit. Care Med., 2014, vol. 183, no. 9, pp. 1164-1175.
8. Pobeha P., Ukropec J., Skyba P. et al. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone, 2011, vol. 48, no. 5, pp. 1008-1014.
9. Rojas E., Rodríguez-Molina D., Bolli P. The role of adiponectin in endothelial dysfunction and hypertension. Curr. Hypertens Rep., 2014, vol. 16, no. 8, – 463 p. doi: 10.1007/s11906-014-0463-7.
10. Takeda Y., Nakanishi K., Tachibana I., Kumanogoh A. Adiponectin: a novel link between adipocytes and COPD. Vitam. Horm., 2012, vol. 90, pp. 419-435.
11. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev.Immunol., 2006, vol. 6, no. 10, pp. 772-783.
12. Vondracek S.F., Voelkel N.F., McDermott M.T., Valdez C. The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis., 2009, vol. 4, pp. 267-277.
13. Withers S.B., Bussey C. E., Saxton S.N. et al. Mechanisms of adiponectin-associated perivascular function in vascular disease. Arterioscler.Thromb.Vasc. Biol., 2014, vol. 34, no. 8, pp. 1637-1642.
14. Wolf I., Sadetzki S., Kanetyh H. et al. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer, 2006, vol. 106, pp. 966-973.
15. Wu N., Wang Q-P., Li H. et al. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and biochemical markers in Chinese women. Clinica Chimica Acta, 2010, vol. 411, pp. 771-775.
16. Zheng Y., Ma., Wang Q. et al. Relation of leptin, ghrelin and inflammatory cytokines with body mass index in pulmonary tuberculosis patients with and without type 2 diabetes mellitus. PLoS One, 2013, vol. 8, no. 11, pp. e80122.
Review
For citations:
Ugay L.G., Nevzorova V.A., Kochetkova E.A., Burtseva E.V., Maystrovskaya Yu.V. LEPTIN AND ADIPONECTIN CONTENT IN BLOOD SERUM AND RECEPTOR EXPRESSION IN OSTEOPENIA AND OSTEOPOROSIS IN PATIENTS SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Tuberculosis and Lung Diseases. 2015;(10):42-49. (In Russ.)
Views:
527
Email this article 